Examining the Crossover Between Biopharma Suppliers with Cultivated Meat & Validating Investment
Time: 2:15 pm
day: Conference Day Two
Details:
- Predicting the scale-up economics of a bioreactor in the context of the product and addressable market
- Carrying out technoeconomic analyses of how process parameters change at scale and overcoming this variability
- Appreciating the limitations of biopharma bioreactors
